Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-20

Clinical Trial Update: Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing topical retinol 1.0% to tretinoin 0.02% for moderate to severe photodamage and wrinkles has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Retinol 1.0% (retinol)
  • Tretinoin 0.02% (tretinoin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Photodamaged Skin, Wrinkles | Phase 2 | Status: COMPLETED | Results posted: 2013-08-20